Symbols

COSM

Cosmos Health·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 1

Bearish signal 2

Bearish Engulfing

Significant Net Income Decline

RSI Oversold

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About COSM

Cosmos Health, Inc.

A global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices

Industry

Healthcare Providers and Services

Established Date

07/21/2009

Listing Date

02/28/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

149

Fiscal Year Ends

12-31

Website

www.cosmoshealthinc.com

Security Type

Common stock

Office address

5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece, 55438

Business

Introduction

Cosmos Health, Inc., was incorporated in Nevada on July 21, 2009. The company is a multinational pharmaceutical company. The company imports, exports and distributes branded and generic drugs, over-the-counter (OTC) drugs and various dietary and vitamin supplement drugs through its established network. The company's cross-border pharmaceutical business serves wholesale pharmaceutical distributors and independent retail pharmacies across the EU through a network of three strategic distribution centers and an additional warehousing facility. The company is focused on leveraging its growing sourcing scale and supplier relationships to secure discounts and deliver medicines at lower prices, and continues to drive organic growth in its cross-border pharmaceutical wholesale business with attractive profit margins.

Company Financials

EPS

COSM has released its 2025 Q3 earnings. EPS was reported at -0.53, versus the expected -0.01, missing expectations. The chart below visualizes how COSM has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

COSM has released its 2025 Q3 earnings report, with revenue of 17.11M, reflecting a YoY change of 37.86%, and net profit of -5.35M, showing a YoY change of -145.26%. The Sankey diagram below clearly presents COSM's revenue sources and cost distribution.